Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Enanta Pharmaceuticals (ENTA) Research & Development: 2011-2025

Historic Research & Development for Enanta Pharmaceuticals (ENTA) over the last 15 years, with Sep 2025 value amounting to $106.7 million.

  • Enanta Pharmaceuticals' Research & Development fell 22.64% to $23.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year decrease of 18.81%. This contributed to the annual value of $106.7 million for FY2025, which is 18.81% down from last year.
  • According to the latest figures from FY2025, Enanta Pharmaceuticals' Research & Development is $106.7 million, which was down 18.81% from $131.5 million recorded in FY2024.
  • In the past 5 years, Enanta Pharmaceuticals' Research & Development registered a high of $174.1 million during FY2021, and its lowest value of $106.7 million during FY2025.
  • In the last 3 years, Enanta Pharmaceuticals' Research & Development had a median value of $131.5 million in 2024 and averaged $133.9 million.
  • Its Research & Development has fluctuated over the past 5 years, first climbed by 27.32% in 2021, then fell by 19.60% in 2024.
  • Over the past 5 years, Enanta Pharmaceuticals' Research & Development (Yearly) stood at $174.1 million in 2021, then declined by 5.51% to $164.5 million in 2022, then decreased by 0.61% to $163.5 million in 2023, then fell by 19.60% to $131.5 million in 2024, then fell by 18.81% to $106.7 million in 2025.